ARC-HBR criteria and TAVR: not all high bleeding risk patients look alike.
Publication
, Journal Article
Krucoff, MW; Cao, D; Mehran, R
Published in: EuroIntervention
August 19, 2022
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
EuroIntervention
DOI
EISSN
1969-6213
Publication Date
August 19, 2022
Volume
18
Issue
6
Start / End Page
448 / 449
Location
France
Related Subject Headings
- Treatment Outcome
- Transcatheter Aortic Valve Replacement
- Risk Factors
- Risk Assessment
- Platelet Aggregation Inhibitors
- Percutaneous Coronary Intervention
- Humans
- Hemorrhage
- 3201 Cardiovascular medicine and haematology
- 0104 Statistics
Citation
APA
Chicago
ICMJE
MLA
NLM
Krucoff, M. W., Cao, D., & Mehran, R. (2022). ARC-HBR criteria and TAVR: not all high bleeding risk patients look alike. EuroIntervention, 18(6), 448–449. https://doi.org/10.4244/EIJ-E-22-00024
Krucoff, Mitchell W., Davide Cao, and Roxana Mehran. “ARC-HBR criteria and TAVR: not all high bleeding risk patients look alike.” EuroIntervention 18, no. 6 (August 19, 2022): 448–49. https://doi.org/10.4244/EIJ-E-22-00024.
Krucoff MW, Cao D, Mehran R. ARC-HBR criteria and TAVR: not all high bleeding risk patients look alike. EuroIntervention. 2022 Aug 19;18(6):448–9.
Krucoff, Mitchell W., et al. “ARC-HBR criteria and TAVR: not all high bleeding risk patients look alike.” EuroIntervention, vol. 18, no. 6, Aug. 2022, pp. 448–49. Pubmed, doi:10.4244/EIJ-E-22-00024.
Krucoff MW, Cao D, Mehran R. ARC-HBR criteria and TAVR: not all high bleeding risk patients look alike. EuroIntervention. 2022 Aug 19;18(6):448–449.
Published In
EuroIntervention
DOI
EISSN
1969-6213
Publication Date
August 19, 2022
Volume
18
Issue
6
Start / End Page
448 / 449
Location
France
Related Subject Headings
- Treatment Outcome
- Transcatheter Aortic Valve Replacement
- Risk Factors
- Risk Assessment
- Platelet Aggregation Inhibitors
- Percutaneous Coronary Intervention
- Humans
- Hemorrhage
- 3201 Cardiovascular medicine and haematology
- 0104 Statistics